alexa
Reach Us +44-1647-403003
In Human Breast Cancer Cells TRβ Competes with ERα for Altering BCl2/Bax Ratio through SMP30-Mediated p53 Induction | OMICS International | Abstract
ISSN: 1948-5956

Journal of Cancer Science & Therapy
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Research Article

In Human Breast Cancer Cells TRβ Competes with ERα for Altering BCl2/Bax Ratio through SMP30-Mediated p53 Induction

Pranati Sar#, Dharmendra K Bhargava#, Debomita Sengupta#, Bandita Rath, Sanjib Chaudhary and Sandip K Mishra*

Cancer Biology Lab, Department of Gene Function and Regulation, Institute of Life Sciences (an Institute under Department of Biotechnology, Govt. of India), Nalco Square, Chandrasekharpur, Bhubaneswar, Odisha, India-751023

#Equal Contribution

*Corresponding Author:
Sandip K Mishra
Scientist D, Molecular Oncology, Gene Function & Regulation
Institute of Life Sciences, Nalco Square
Chandrasekharpur, Bhubaneswar, Odisha, India-751023
Tel: +91 0674 2300702
Fax: +91 674 2300728
E-mail: [email protected], [email protected]

Received Date: June 15, 2012; Accepted Date: July 24, 2012; Published Date: July 26, 2012

Citation: Sar P, Bhargava DK, Sengupta D, Rath B, Chaudhary S, et al. (2012) In Human Breast Cancer Cells TRβ Competes with ERα for Altering BCl2/Bax Ratio through SMP30-Mediated p53 Induction. J Cancer Sci Ther 4:227-234. doi:10.4172/1948-5956.1000146

Copyright: © 2012 Sar P, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Abstract

Thyroid hormone and Estrogen regulate transcription(s) of target genes by binding to their nuclear receptors that interact with specific responsive elements -TRE and ERE, respectively. Recently, we have demonstrated that 3, 3’5 Triiodo L Thyronine (T3) can induce apoptosis in ER positive breast cancer cells (MCF-7) through downregulation of Senescence Marker Protein-30 (SMP30) gene. SMP30, a novel age-associated protein which decreases during ageing is highly expressed in hepatocytes and in renal tubular epithelia. Earlier reports suggest that SMP30 too plays a diverse role in proliferation, survival and differentiation of the cells. SMP30 has also been reported to be downregulated by 17β-Estradiol (E2) in prostate gland and mammary epithelial cells. Interestingly, Thyroid Receptors (TRs) and Estrogen Receptors (ERs) share a common consensus half site sequence. In this context; we hypothesize a possible competition between both the receptors in SMP30 promoter under different types of hormonal signaling. To prove this hypothesis, gel retardation and luciferase assays were conducted by taking hSMP30 promoter reporter constructs which validated our findings for the putative ERE site. Competition Chromatin Immunoprecipitation Assay (ChIP) in the above mentioned ERE showed differential TRβ binding upon thyroid/estrogen hormone treatment, while ERα showed binding mainly in control and estrogen treated sample. Although the SMP30 promoter activity was almost same in response to E2 and T3, but the functional consequences of down regulation of SMP30 in human breast cancer cells post E2/T3 treatment were different in terms of apoptosis. To unravel the mechanism behind the differential consequences of E2/T3 treatment, in addition to looking at the expression of regular apoptotic markers such as Bax and Cleaved PARP, we have also tried to verify the possible involvement of p53, which has been already reported to be a downstream target of SMP30.

Share This Page
Top